Related Items Sixth Annual New York Lung Cancer Symposium OOTR the 7th Annual Conference – Future in Oncology: What’s in it for us? OOTR the 7th Annual Conference – Future in Oncology: What’s in it for us? 16th Annual Cancer Conference – Pakistan Society of Clinical Oncology Annual National Bowel Cancer Seminar – Irish Cancer ...
HemaQuest Pharmaceuticals announced that it has initiated the Company’s Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related ...
This publication belongs to the successful book series “Cancer Drug Discovery and Development.” The book provides an excellent guide over the experimental procedures developed in attempt to improve the treatment of malignancies. This publication represents an outstanding work devoted to the current state-of-the-art of the in vivo tumor models available for cancer research. The book ...
